NEW YORK (GenomeWeb News) – CLC bio has been awarded a $2 million grant from the European Union to develop a software platform to support a multi-partner project using next-generation sequencing to identify infections, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.